ES476427A1 - Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas. - Google Patents

Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas.

Info

Publication number
ES476427A1
ES476427A1 ES476427A ES476427A ES476427A1 ES 476427 A1 ES476427 A1 ES 476427A1 ES 476427 A ES476427 A ES 476427A ES 476427 A ES476427 A ES 476427A ES 476427 A1 ES476427 A1 ES 476427A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
alkanoyl
analgesic
dione
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476427A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES476427A1 publication Critical patent/ES476427A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • C07D251/46One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para preparar tetrahidro- 1,3,5-triazina-2,6-diona, de fórmula **fórmula** dónde R1 es un radical alquilo C1-6; y R2 es un radical alquilo C1-4, un radical cicloalquilo C3-8 o alquenilo C3-6, un radical alquilo C5-10 en donde el átomo de carbono alfa de enlace es secundario, un radical bencilo ó 1-(fenil)etilo ó un radical fenilo portando opcionalmente un sustituyente aromático seleccionado entre átomos de halógeno , radicales alquilo C1-4 y alcoxi C1-4; o en donde R1 es un radical n-propilo o etilo y R2 es un radical n-propilo; o en donde R1 es un radical isopropilo y R2 es un radical n-propilo; o en donde R1 es un radical isopropilo y R2 es un radical 3,3-dimetilbutilo; o una sal farmacéuticamente aceptable de las mismas; caracterizado porque se transpone un compuesto de fórmula** fórmula** bajo la influencia de calor a una temperatura de 60 a 200ºC, tras lo cual cuando se requiera una sal de adición de base farmaceúticamente aceptable, se hace reaccionar un compuesto de fórmula I con una base adecuada..
ES476427A 1977-02-21 1978-12-28 Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas. Expired ES476427A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7183/77A GB1599518A (en) 1977-02-21 1977-02-21 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
ES476427A1 true ES476427A1 (es) 1979-04-16

Family

ID=9828208

Family Applications (3)

Application Number Title Priority Date Filing Date
ES467170A Expired ES467170A1 (es) 1977-02-21 1978-02-21 Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas
ES476428A Expired ES476428A1 (es) 1977-02-21 1978-12-28 Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas.
ES476427A Expired ES476427A1 (es) 1977-02-21 1978-12-28 Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES467170A Expired ES467170A1 (es) 1977-02-21 1978-02-21 Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas
ES476428A Expired ES476428A1 (es) 1977-02-21 1978-12-28 Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas.

Country Status (32)

Country Link
US (1) US4156002A (es)
JP (1) JPS53105487A (es)
AR (1) AR220120A1 (es)
AT (1) AT358592B (es)
AU (1) AU519803B2 (es)
BE (1) BE864124A (es)
CA (1) CA1117867A (es)
CH (1) CH637646A5 (es)
CS (2) CS208463B2 (es)
DD (1) DD134091A5 (es)
DE (1) DE2807381A1 (es)
DK (1) DK67978A (es)
ES (3) ES467170A1 (es)
FI (1) FI64152C (es)
FR (1) FR2381034A1 (es)
GB (1) GB1599518A (es)
GR (1) GR62157B (es)
HU (2) HU182653B (es)
IE (1) IE46650B1 (es)
IL (1) IL54026A (es)
IT (1) IT1158652B (es)
LU (1) LU79092A1 (es)
MW (1) MW478A1 (es)
NL (1) NL7801921A (es)
NO (1) NO780576L (es)
NZ (1) NZ186406A (es)
PL (2) PL109995B1 (es)
PT (1) PT67668B (es)
SE (1) SE440775B (es)
SU (2) SU890976A3 (es)
ZA (1) ZA78671B (es)
ZM (1) ZM1878A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005911B1 (en) * 1978-05-26 1982-02-17 Imperial Chemical Industries Plc Analgesic 6-acylaminotetrahydro-1,3,5-triazine-2,4-dione derivatives, pharmaceutical compositions thereof, and process for their manufacture
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
CA2752269C (en) * 2009-02-13 2016-08-30 Hiroyuki Kai Novel triazine derivative and pharmaceutical composition comprising the same
JP6075621B2 (ja) 2010-08-10 2017-02-08 塩野義製薬株式会社 新規複素環誘導体およびそれらを含有する医薬組成物
WO2012020749A1 (ja) 2010-08-10 2012-02-16 塩野義製薬株式会社 トリアジン誘導体およびそれを含有する鎮痛作用を有する医薬組成物
WO2013118855A1 (ja) 2012-02-09 2013-08-15 塩野義製薬株式会社 複素環および炭素環誘導体
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK117230B (da) * 1965-07-21 1970-03-31 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 1-phenyl- eller -cyclohexyl-5-(γ-carboxypropyl-, γ-hydroxy-n-butyl-, β-acetylethyl- eller γ-hydroxy-n-butyl)-barbitursyrer eller salte deraf.
GB1543037A (en) * 1975-02-05 1979-03-28 Ici Ltd Selective herbicidal triazine-diones
US4035365A (en) * 1973-11-01 1977-07-12 Imperial Chemical Industries Limited Triazinediones
JPS5623425B2 (es) * 1973-11-09 1981-05-30

Also Published As

Publication number Publication date
IE46650B1 (en) 1983-08-10
PT67668A (en) 1978-03-01
IL54026A (en) 1983-06-15
FI64152C (fi) 1983-10-10
FR2381034A1 (fr) 1978-09-15
CS208464B2 (en) 1981-09-15
PL107871B1 (pl) 1980-03-31
NO780576L (no) 1978-08-22
US4156002A (en) 1979-05-22
IT7820500A0 (it) 1978-02-21
PL109995B1 (en) 1980-06-30
GB1599518A (en) 1981-10-07
SE7801930L (sv) 1978-08-22
PL204641A1 (pl) 1978-12-04
DD134091A5 (de) 1979-02-07
ZA78671B (en) 1978-12-27
JPS53105487A (en) 1978-09-13
HU176980B (hu) 1981-06-28
NL7801921A (nl) 1978-08-23
ES467170A1 (es) 1979-08-16
AR220120A1 (es) 1980-10-15
MW478A1 (en) 1980-02-13
FI64152B (fi) 1983-06-30
ZM1878A1 (en) 1981-06-22
CS208463B2 (en) 1981-09-15
ATA127178A (de) 1980-02-15
CH637646A5 (de) 1983-08-15
GR62157B (en) 1979-03-01
NZ186406A (en) 1984-08-24
AT358592B (de) 1980-09-25
IT1158652B (it) 1987-02-25
LU79092A1 (fr) 1979-05-25
SU890976A3 (ru) 1981-12-15
FR2381034B1 (es) 1980-09-19
HU182653B (en) 1984-02-28
PT67668B (en) 1979-09-20
IE780217L (en) 1978-08-21
AU519803B2 (en) 1981-12-24
DE2807381A1 (de) 1978-08-24
ES476428A1 (es) 1979-05-01
FI780529A (fi) 1978-08-22
DK67978A (da) 1978-08-22
BE864124A (fr) 1978-08-21
AU3311278A (en) 1979-08-16
SU867303A3 (ru) 1981-09-23
CA1117867A (en) 1982-02-09
SE440775B (sv) 1985-08-19

Similar Documents

Publication Publication Date Title
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
SE8300736D0 (sv) Novel pharmacologically active compounds
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
PT100514A (pt) 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem
PT1227806E (pt) Formulacao farmaceutica contendo tolterodina e sua utilizacao
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
ATE103808T1 (de) N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.
SE9901573D0 (sv) New compounds
RU95122135A (ru) Комбинация для профилактики и лечения спида, фармацевтическая композиция на ее основе
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
ES476428A1 (es) Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas.
FI972434A (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
TR199701497T1 (xx) Beyin �demini �nleyen terkip.
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
SE9901572D0 (sv) New compounds
HUP9900507A2 (hu) Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmények előállítására
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
YU233090A (sh) Karbamoilni derivati
MY133438A (en) Morpholinobenzamide salts
NO950177D0 (no) Farmakologisk aktive erivater
SE8700829L (sv) Farmaceutisk komposition
KR940002268A (ko) 21-클로로-프레그난 유도체
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405